Vireo Growth Inc. (VREOF) income statement
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026Market cap $406.23MP/E –Yield –
Vireo Growth Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 48.6%
- Operating margin
- 0.3%
- Net margin
- -13.1%
- Return on equity, FY2025
- -37.5%
Financial strength
- Current ratio
- 1.01
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 26.4%
Valuation
- P/E ratio
- –
- Price to sales
- 0.79
- Price to book
- 0.92
- Dividend yield
- –
See a number that looks wrong?